Integrated BioPharma
(OTC) INBP
Integrated BioPharma Financials at a Glance
Market Cap
$9.01M
Revenue (TTM)
$52.09M
Net Income (TTM)
$206.00K
EPS (TTM)
$-0.01
P/E Ratio
-41.43
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.29
Volume
1,000
Open
$0.29
Price
$0.29
Volume
1,000
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.29
52-Week Range
$0.25 - $0.42
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.29
Volume
1,000
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.29
52-Week Range
$0.25 - $0.42
INBP News
INBP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Integrated BioPharma
Industry
Personal Products
Sector
Consumer StaplesEmployees
153
CEO
Christina Kay; Riva Kay Sheppard
Website
ir.ibiopharma.comHeadquarters
Hillside, NJ 07205, US
INBP Financials
Key Financial Metrics (TTM)
Gross Margin
8%
Operating Margin
1%
Net Income Margin
-0%
Return on Equity
-1%
Return on Capital
3%
Return on Assets
-1%
Earnings Yield
-2.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.01M
Shares Outstanding
31.06M
Volume
1.00K
Short Interest
0.00%
Avg. Volume
12.85K
Financials (TTM)
Gross Profit
$5.56M
Operating Income
$2.02M
EBITDA
$3.38M
Operating Cash Flow
$2.06M
Capital Expenditure
$191.00K
Free Cash Flow
$1.87M
Cash & ST Invst.
$3.62M
Total Debt
$1.01M
Integrated BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.28M
-10.6%
Gross Profit
$29.00K
-97.5%
Gross Margin
0.26%
N/A
Market Cap
$9.01M
N/A
Market Cap/Employee
$61.27K
N/A
Employees
147
N/A
Net Income
$762.00K
-756.9%
EBITDA
$583.00K
-212.1%
Quarterly Fundamentals
Net Cash
$4.67M
+309.9%
Accounts Receivable
$3.59M
-15.0%
Inventory
$8.36M
-24.4%
Long Term Debt
$382.00K
+6.4%
Short Term Debt
$267.00K
-72.3%
Return on Assets
-0.87%
N/A
Return on Invested Capital
2.88%
N/A
Free Cash Flow
$593.00K
+244.8%
Operating Cash Flow
$617.00K
+207.0%